Source: https://regulations.justia.com/regulations/fedreg/2017/10/12/2017-22068.html
Timestamp: 2020-08-09 09:26:34
Document Index: 154701361

Matched Legal Cases: ['art; 2015', 'art; 2015', 'art; 2015', 'art; 2015', 'art; 2015', 'art; 2015', 'art; 2015', 'art; 2015', 'art; 2015']

Glycine From the People's Republic of China: Final Results of Antidumping Duty Administrative Review and Rescission of Administrative Review, in Part; 2015-2016, 47474-47475 [2017-22068] :: International Trade Administration :: Department Of Commerce :: Regulation Tracker :: Justia
Justia Regulation Tracker Department Of Commerce International Trade Administration Glycine From the People's Republic of China: Final Results of Antidumping Duty Administrative Review and Rescission of Administrative Review, in Part; 2015-2016, 47474-47475 [2017-22068]
Glycine From the People's Republic of China: Final Results of Antidumping Duty Administrative Review and Rescission of Administrative Review, in Part; 2015-2016, 47474-47475 [2017-22068]
Download as PDF 47474 Federal Register / Vol. 82, No. 196 / Thursday, October 12, 2017 / Notices CPEC’s amendment of its Export Trade Certificate of Review results in the following membership list: • Arizona Nut Company, LLC • ARO Pistachios, Inc. • Horizon Growers Cooperative, Inc. • Keenan Farms, Inc. • Monarch Nut Company • Nichols Pistachio • Primex Farms, LLC • Setton Pistachio of Terra Bella, Inc. • Zymex Industries, Inc. No change has been made regarding the Export Trade, Export Trade Activities or Methods of Operation covered by the Certificate. The amended Certificate of Review is effective from June 15, 2017, the date on which the application for an amendment was deemed submitted. Dated: October 5, 2017. Joseph E. Flynn, Director, Office of Trade and Economic Analysis, International Trade Administration. [FR Doc. 2017–21984 Filed 10–11–17; 8:45 am] DEPARTMENT OF COMMERCE International Trade Administration [A–570–836] Glycine From the People’s Republic of China: Final Results of Antidumping Duty Administrative Review and Rescission of Administrative Review, in Part; 2015–2016 Enforcement and Compliance, International Trade Administration, Department of Commerce. SUMMARY: On April 7, 2017, the Department of Commerce (the Department) published the preliminary results of the administrative review of the antidumping duty order on glycine from the People’s Republic of China (PRC), covering the period March 1, 2015, through February 29, 2016. We invited interested parties to comment on the preliminary results. We received comments from a domestic interested party, GEO Specialty Chemicals, Inc. (GEO), a respondent, Baoding Mantong Fine Chemistry Co., Ltd. (Baoding Mantong) and a U.S. importer, PharmRx Chemical Corporation (Pharm-Rx). As a result of comments filed by the parties, we have determined that the U.S. sale reported by Baoding Mantong is not a bona fide sale and the review should be rescinded with respect to this exporter. The final results remain unchanged from the preliminary results of review with respect to the other respondent, Jizhou City Huayang Chemical Co., Ltd. (Huayang Chemical). asabaliauskas on DSKBBXCHB2PROD with NOTICES AGENCY: 22:35 Oct 11, 2017 Applicable October 12, 2017. FOR FURTHER INFORMATION CONTACT: Edythe Artman or Brian Davis, AD/CVD Operations, Office VI, Enforcement and Compliance, International Trade Administration, U.S. Department of Commerce, 1401 Constitution Avenue NW., Washington, DC 20230; telephone: (202) 482–3931 or (202) 482–7924, respectively. Background On April 7, 2017, the Department published its notice of preliminary results of review for the administrative review on glycine from the PRC in the Federal Register.1 A summary of the events that occurred since the Department published these results, as well as a discussion of the issues raised by parties for this final determination, may be found in the Issues and Decision Memorandum, which is hereby adopted by this notice.2 Scope of the Order BILLING CODE 3510–DR–P VerDate Sep<11>2014 DATES: Jkt 244001 The product covered by this antidumping duty order is glycine, which is a free-flowing crystalline material, like salt or sugar. Glycine is produced at varying levels of purity and is used as a sweetener/taste enhancer, a buffering agent, reabsorbable amino acid, chemical intermediate, and a metal complexing agent. This proceeding includes glycine of all purity levels. Glycine is currently classified under subheading 2922.49.4020 of the Harmonized Tariff Schedule of the United States (HTSUS).3 Although the HTSUS subheading is provided for convenience and customs purposes, the written description of the merchandise under the order is dispositive. 1 See Glycine from the People’s Republic of China: Preliminary Results of Antidumping Duty Administrative Review and Rescission of Antidumping Duty Administrative Review, In Part; 2015–2016, 82 FR 16992 (April 7, 2017) (Preliminary Results). 2 See Memorandum to Gary Taverman, Deputy Assistant Secretary for Antidumping and Countervailing Duty Operations, on the subject of ‘‘Glycine from the People’s Republic of China: Issues and Decision Memorandum for the Final Results of Administrative Review and Rescission of Review, In Part; 2015–2016’’, dated concurrently with this notice (Issues and Decision Memorandum). 3 In separate scope rulings, the Department determined that: (a) D(-) Phenylglycine Ethyl Dane Salt is outside the scope of the order and (b) PRCglycine exported from India remains the same class or kind of merchandise as the PRC-origin glycine imported into India. See Notice of Scope Rulings and Anticircumvention Inquiries, 62 FR 62288 (November 21, 1997) and Glycine from the People’s Republic of China: Final Partial Affirmative Determination of Circumvention of the Antidumping Duty Order, 77 FR 73426 (December 10, 2012), respectively. PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 Analysis of Comments Received All issues raised in the case and rebuttal briefs by parties to this administrative review are addressed in the Issues and Decision Memorandum. A list of the issues raised by parties is attached to this notice as Appendix I. The Issues and Decision Memorandum is a public document and is on file electronically via Enforcement and Compliance’s Antidumping and Countervailing Duty Centralized Electronic Service System (ACCESS). ACCESS is available to registered users at https://access.trade.gov and it is available to all parties in the Central Records Unit, Room B8024 of the main Department of Commerce building. In addition, a complete version of the Issues and Decision Memorandum can be accessed directly at http:// enforcement.trade.gov/frn/index.html. The signed and electronic versions of the Issues and Decision Memorandum are identical in content. Changes Since the Preliminary Results In Comment 1 of the Issues and Decision Memorandum, the Department concluded that the sole U.S. sale reported by Baoding Mantong for the period of review was not a bona fide sale. Consequently, we are rescinding the review with respect to this company. We made no changes to the PRC-wide rate assigned to Pharm-Rx’s Chinese supplier, Huayang Chemical, as a result of our analysis of the issues. Final Results of Review In the Preliminary Results, we determined that Huayang Chemical failed to establish its eligibility for a separate rate and preliminarily determined to treat the exporter as part of the PRC-wide entity.4 Because no party requested a review of the PRCwide entity and the Department no longer considers the PRC-wide entity as an exporter conditionally subject to administrative reviews, we did not conduct a review of the PRC-wide entity, and the entity’s rate is not subject to change in this review.5 Assessment Rates Pursuant to section 751(a)(2)(C) of the Tariff Act of 1930, as amended (the Act) and 19 CFR 351.212(b), the Department has determined, and CBP shall assess, antidumping duties on all appropriate entries of subject merchandise covered 4 See Preliminary Results at 16992–16993. Antidumping Proceedings: Announcement of Change in Department Practice for Respondent Selection in Antidumping Duty Proceedings and Conditional Review of the Nonmarket Economy Entity in NME Antidumping Duty Proceedings, 78 FR 65963 (November 4, 2013). 5 See E:\FR\FM\12OCN1.SGM 12OCN1 Federal Register / Vol. 82, No. 196 / Thursday, October 12, 2017 / Notices by this review. The Department intends to issue assessment instructions to CBP 15 days after the date of publication of these final results of review. Accordingly, we will instruct CBP to liquidate the entries reported by Baoding Mantong without regard to antidumping duties. The Department also intends to instruct CBP to liquidate entries of subject merchandise from the exporters identified above as being part of the PRC-wide entity (including Huayang Chemical) at the PRC-wide rate, i.e., 453.79 percent. Pursuant to a refinement in the Department’s non-market economy practice, for entries that were not reported in the U.S. sales databases submitted by companies individually examined during this review, the Department will instruct CBP to liquidate such entries at the PRC-wide rate.6 Additionally, if the Department determines that an exporter had no shipments of the subject merchandise, any suspended entries that entered under that exporter’s case number (i.e., at that exporter’s rate) will be liquidated at the PRC-wide rate.7 asabaliauskas on DSKBBXCHB2PROD with NOTICES Cash Deposit Requirements The following cash deposit requirements will be effective for all shipments of subject merchandise entered, or withdrawn from warehouse, for consumption on or after the publication date of the final results of this administrative review, as provided by section 751(a)(2)(C) of the Act: (1) For Baoding Mantong and other previously investigated or reviewed PRC and non-PRC exporters which are not under review in this segment of the proceeding but received a separate rate in a previous segment, the cash deposit rate will continue to be the exporterspecific rate published for the most recently-completed period; (2) for all PRC exporters of subject merchandise which have not been found to be entitled to a separate rate, the cash deposit rate will be that for the PRCwide entity (i.e., 453.79 percent); and (3) for all non-PRC exporters of subject merchandise which have not received their own rate, the cash deposit rate will be the rate applicable to the PRC exporter(s) that supplied the non-PRC exporter. These cash deposit requirements, when imposed, shall remain in effect until further notice. 6 See Non-Market Economy Antidumping Proceedings: Assessment of Antidumping Duties, 76 FR 65694 (October 24, 2011). 7 Id. VerDate Sep<11>2014 22:35 Oct 11, 2017 Jkt 244001 47475 Notification to Importers DEPARTMENT OF COMMERCE This notice serves as a final reminder to importers of their responsibility under 19 CFR 351.402(f)(2) to file a certificate regarding the reimbursement of antidumping duties prior to liquidation of the relevant entries during this period of review. Failure to comply with this requirement could result in the Department’s presumption that reimbursement of antidumping duties occurred and the subsequent assessment of double antidumping duties. International Trade Administration Notification Regarding Administrative Protective Order This notice also serves as a final reminder to parties subject to administrative protective order (APO) of their responsibility concerning the return or destruction of proprietary information disclosed under APO in accordance with 19 CFR 351.305(a)(3), which continues to govern business proprietary information in this segment of the proceeding. Timely written notification of the return or destruction of APO materials, or conversion to judicial protective order, is hereby requested. Failure to comply with the regulations and terms of an APO is a sanctionable violation. We are issuing and publishing these results and this notice in accordance with sections 751(a)(1) and 777(i) of the Act. Dated: October 4, 2017. Gary Taverman, Deputy Assistant Secretary for Antidumping and Countervailing Duty Operations performing the non-exclusive functions and duties of the Assistant Secretary for Enforcement and Compliance. Appendix I List of Topics Discussed in the Final Issues and Decision Memorandum I. Summary II. List of Issues III. Background IV. Scope of the Order V. Discussion of Interested Party Comments Comment 1: Bona Fides of Baoding Mantong’s U.S. Sale Comment 2: Moot Arguments Concerning Baoding Mantong’s Margin Calculations Comment 3: Assignment of the PRC-Wide Rate to Pharm-Rx Following Judicial Review of the Rate VI. Recommendation [FR Doc. 2017–22068 Filed 10–11–17; 8:45 am] BILLING CODE 3510–DS–P PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 [A–403–805] Silicon Metal From Norway: Preliminary Affirmative Determination of Sales at Less Than Fair Value, Preliminary Negative Determination of Critical Circumstances, Preliminary Determination of No Shipments, Postponement of Final Determination, and Extension of Provisional Measures Enforcement and Compliance, International Trade Administration, Department of Commerce. SUMMARY: The Department of Commerce (the Department) preliminarily determines that silicon metal from Norway is being, or is likely to be, sold in the United States at less than fair value (LTFV). The period of investigation (POI) is January 1, 2016, through December 31, 2016. DATES: Applicable October 12, 2017. FOR FURTHER INFORMATION CONTACT: Brittany Bauer, AD/CVD Operations, Office II, Enforcement and Compliance, International Trade Administration, U.S. Department of Commerce, 1401 Constitution Avenue NW., Washington, DC 20230; telephone: (202) 482–3860. SUPPLEMENTARY INFORMATION: AGENCY: Background This preliminary determination is made in accordance with section 733(b) of the Tariff Act of 1930, as amended (the Act). The Department published the notice of initiation of this investigation on April 4, 2017.1 On July 26, 2017, the Department postponed the preliminary determination of this investigation, and the revised deadline is now October 4, 2017.2 For a complete description of the events that followed the initiation of this investigation, see the Preliminary Decision Memorandum.3 A list of topics included in the Preliminary Decision Memorandum is included as Appendix II to this notice. The Preliminary Decision Memorandum is a public document and is on file electronically via Enforcement and Compliance’s Antidumping and Countervailing Duty 1 See Silicon Metal From Australia, Brazil, and Norway: Initiation of Less-Than-Fair-Value Investigations, 82 FR 16352 (April 4, 2017) (Initiation Notice). 2 See Silicon Metal from Australia, Brazil, and Norway: Postponement of Preliminary Determinations in the Less-Than-Fair-Value Investigations, 82 FR 35753 (August 1, 2017). 3 See Memorandum, ‘‘Decision Memorandum for the Preliminary Determination in the Less-ThanFair-Value Investigation of Silicon Metal from Norway,’’ dated concurrently with, and hereby adopted by, this notice (Preliminary Decision Memorandum). E:\FR\FM\12OCN1.SGM 12OCN1
[FR Doc No: 2017-22068]
Antidumping Duty Administrative Review and Rescission of Administrative
Review, in Part; 2015-2016
SUMMARY: On April 7, 2017, the Department of Commerce (the Department)
(PRC), covering the period March 1, 2015, through February 29, 2016. We
received comments from a domestic interested party, GEO Specialty
Chemicals, Inc. (GEO), a respondent, Baoding Mantong Fine Chemistry
Co., Ltd. (Baoding Mantong) and a U.S. importer, Pharm-Rx Chemical
Corporation (Pharm-Rx). As a result of comments filed by the parties,
we have determined that the U.S. sale reported by Baoding Mantong is
not a bona fide sale and the review should be rescinded with respect to
this exporter. The final results remain unchanged from the preliminary
results of review with respect to the other respondent, Jizhou City
Huayang Chemical Co., Ltd. (Huayang Chemical).
NW., Washington, DC 20230; telephone: (202) 482-3931 or (202) 482-7924,
On April 7, 2017, the Department published its notice of
preliminary results of review for the administrative review on glycine
from the PRC in the Federal Register.\1\ A summary of the events that
occurred since the Department published these results, as well as a
Results of Antidumping Duty Administrative Review and Rescission of
Antidumping Duty Administrative Review, In Part; 2015-2016, 82 FR
16992 (April 7, 2017) (Preliminary Results).
for Antidumping and Countervailing Duty Operations, on the subject
of ``Glycine from the People's Republic of China: Issues and
Decision Memorandum for the Final Results of Administrative Review
and Rescission of Review, In Part; 2015-2016'', dated concurrently
United States (HTSUS).\3\ Although the HTSUS subheading is provided for
\3\ In separate scope rulings, the Department determined that:
62 FR 62288 (November 21, 1997) and Glycine from the People's
Republic of China: Final Partial Affirmative Determination of
Circumvention of the Antidumping Duty Order, 77 FR 73426 (December
10, 2012), respectively.
Memorandum. A list of the issues raised by parties is attached to this
In Comment 1 of the Issues and Decision Memorandum, the Department
concluded that the sole U.S. sale reported by Baoding Mantong for the
period of review was not a bona fide sale. Consequently, we are
rescinding the review with respect to this company. We made no changes
to the PRC-wide rate assigned to Pharm-Rx's Chinese supplier, Huayang
Chemical, as a result of our analysis of the issues.
In the Preliminary Results, we determined that Huayang Chemical
failed to establish its eligibility for a separate rate and
preliminarily determined to treat the exporter as part of the
PRC[hyphen]wide entity.\4\ Because no party requested a review of the
PRC-wide entity and the Department no longer considers the PRC-wide
entity as an exporter conditionally subject to administrative reviews,
we did not conduct a review of the PRC-wide entity, and the entity's
rate is not subject to change in this review.\5\
\4\ See Preliminary Results at 16992-16993.
amended (the Act) and 19 CFR 351.212(b), the Department has determined,
and CBP shall assess, antidumping duties on all appropriate entries of
subject merchandise covered
by this review. The Department intends to issue assessment instructions
review. Accordingly, we will instruct CBP to liquidate the entries
reported by Baoding Mantong without regard to antidumping duties. The
Department also intends to instruct CBP to liquidate entries of subject
merchandise from the exporters identified above as being part of the
PRC-wide entity (including Huayang Chemical) at the PRC-wide rate,
i.e., 453.79 percent.
practice, for entries that were not reported in the U.S. sales
the PRC-wide rate.\6\ Additionally, if the Department determines that
exporter's rate) will be liquidated at the PRC-wide rate.\7\
the Act: (1) For Baoding Mantong and other previously investigated or
reviewed PRC and non-PRC exporters which are not under review in this
specific rate published for the most recently-completed period; (2) for
be entitled to a separate rate, the cash deposit rate will be that for
the PRC-wide entity (i.e., 453.79 percent); and (3) for all non-PRC
Comment 1: Bona Fides of Baoding Mantong's U.S. Sale
Comment 2: Moot Arguments Concerning Baoding Mantong's Margin
Comment 3: Assignment of the PRC-Wide Rate to Pharm-Rx Following
Judicial Review of the Rate
[FR Doc. 2017-22068 Filed 10-11-17; 8:45 am]